HBW InsightMasimo Corp. has received US regulatory clearance for its Stork OTC baby monitoring system six months after a competitor pioneered the market following its regulatory stumble which halted sales of a
Medtech InsightMasimo Corp. has received US regulatory clearance for its Stork OTC baby monitoring system six months after a competitor pioneered the market following its regulatory stumble which halted sales of a
ScripAdvantages of Corporate Simplification Masimo Corp. ’s recent announcement of the separation of its consumer business marked the latest in a long line of corporate simplifications by former healthc
Medtech InsightMasimo is launching MightySat Medical, the first over-the-counter fingertip pulse oximeter to receive clearance from the US Food and Drug Administration. The device, which costs $299, was ruled as